• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

周期蛋白2:乳腺癌中的一种肿瘤抑制基因。

Period-2: a tumor suppressor gene in breast cancer.

作者信息

Xiang Shulin, Coffelt Seth B, Mao Lulu, Yuan Lin, Cheng Qi, Hill Steven M

机构信息

Department of Structural and Cellular Biology, Tulane University Health Sciences Center, New Orleans, LA 70112, USA.

出版信息

J Circadian Rhythms. 2008 Mar 11;6:4. doi: 10.1186/1740-3391-6-4.

DOI:10.1186/1740-3391-6-4
PMID:18334030
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2365929/
Abstract

Previous reports have suggested that the ablation of the Period 2 gene (Per 2) leads to enhanced development of lymphoma and leukemia in mice. Employing immunoblot analyses, we have demonstrated that PER 2 is endogenously expressed in human breast epithelial cell lines but is not expressed or is expressed at significantly reduced level in human breast cancer cell lines. Expression of PER 2 in MCF-7 breast cancer cells significantly inhibited the growth of MCF-7 human breast cancer cells, and, when PER 2 was co-expressed with the Crytochrome 2 (Cry 2) gene, an even greater growth-inhibitory effect was observed. The inhibitory effect of PER 2 on breast cancer cells was also demonstrated by its suppression of the anchorage-independent growth of MCF-7 cells as evidenced by the reduced number and size of colonies. A corresponding blockade of MCF-7 cells in the G1 phase of the cell cycle was also observed in response to the expression of PER 2 alone or in combination with CRY 2. Expression of PER 2 also induced apoptosis of MCF-7 breast cancer cells as demonstrated by an increase in PARP [poly (ADP-ribose) polymerase] cleavage. Finally, our studies demonstrate that PER 2 expression in MCF-7 breast cancer cells is associated with a significant decrease in the expression of cyclin D1 and an up-regulation of p53 levels.

摘要

先前的报道表明,Period 2基因(Per 2)的缺失会导致小鼠淋巴瘤和白血病的发展加剧。通过免疫印迹分析,我们证明PER 2在人乳腺上皮细胞系中内源性表达,但在人乳腺癌细胞系中不表达或表达水平显著降低。PER 2在MCF-7乳腺癌细胞中的表达显著抑制了MCF-7人乳腺癌细胞的生长,并且,当PER 2与细胞色素2(Cry 2)基因共表达时,观察到了更强的生长抑制作用。PER 2对乳腺癌细胞的抑制作用还通过其对MCF-7细胞非锚定依赖性生长的抑制得以证明,这表现为集落数量和大小的减少。单独表达PER 2或与CRY 2共同表达时,还观察到MCF-7细胞在细胞周期的G1期相应受阻。PER 2的表达还诱导了MCF-7乳腺癌细胞的凋亡,这通过聚(ADP-核糖)聚合酶(PARP)裂解增加得以证明。最后,我们的研究表明,MCF-7乳腺癌细胞中PER 2的表达与细胞周期蛋白D1表达的显著降低和p53水平的上调有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc8/2365929/192866c13093/1740-3391-6-4-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc8/2365929/c29dacf263ac/1740-3391-6-4-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc8/2365929/f7dc022b68a8/1740-3391-6-4-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc8/2365929/7c62b1d75bfe/1740-3391-6-4-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc8/2365929/2f76bdd76391/1740-3391-6-4-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc8/2365929/192866c13093/1740-3391-6-4-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc8/2365929/c29dacf263ac/1740-3391-6-4-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc8/2365929/f7dc022b68a8/1740-3391-6-4-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc8/2365929/7c62b1d75bfe/1740-3391-6-4-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc8/2365929/2f76bdd76391/1740-3391-6-4-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc8/2365929/192866c13093/1740-3391-6-4-5.jpg

相似文献

1
Period-2: a tumor suppressor gene in breast cancer.周期蛋白2:乳腺癌中的一种肿瘤抑制基因。
J Circadian Rhythms. 2008 Mar 11;6:4. doi: 10.1186/1740-3391-6-4.
2
Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity.金雀花碱通过抑制拓扑异构酶活性在乳腺癌细胞中具有抗癌活性。
Int J Cancer. 2012 Apr 1;130(7):1660-70. doi: 10.1002/ijc.26158. Epub 2011 Aug 16.
3
Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.紫杉醇诱导的细胞生长停滞和凋亡与细胞周期蛋白依赖性激酶抑制剂 p21WAF1/CIP1 在人乳腺癌细胞中的上调有关。
Oncol Rep. 2012 Dec;28(6):2163-9. doi: 10.3892/or.2012.2060. Epub 2012 Sep 26.
4
Benzofuran-2-acetic ester derivatives induce apoptosis in breast cancer cells by upregulating p21 gene expression in p53-independent manner.苯并呋喃-2-乙酸酯衍生物通过以不依赖p53的方式上调p21基因表达来诱导乳腺癌细胞凋亡。
DNA Repair (Amst). 2017 Mar;51:20-30. doi: 10.1016/j.dnarep.2017.01.006. Epub 2017 Jan 15.
5
Poly(ADP-ribose) polymerase as a novel regulator of 17β-estradiol-induced cell growth through a control of the estrogen receptor/IGF-1 receptor/PDZK1 axis.聚(ADP - 核糖)聚合酶作为17β - 雌二醇诱导细胞生长的新型调节因子,通过控制雌激素受体/胰岛素样生长因子 - 1受体/PDZK1轴发挥作用。
J Transl Med. 2015 Jul 17;13:233. doi: 10.1186/s12967-015-0589-7.
6
Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.抗肥胖药物奥利司他(赛尼可TM)对乳腺癌细胞的抗肿瘤作用:阻断细胞周期进程、促进凋亡性细胞死亡以及PEA3介导的Her2/neu(erbB-2)癌基因转录抑制。
Ann Oncol. 2005 Aug;16(8):1253-67. doi: 10.1093/annonc/mdi239. Epub 2005 May 3.
7
Novel triterpenoid 25-hydroxy-3-oxoolean-12-en-28-oic acid induces growth arrest and apoptosis in breast cancer cells.新型三萜类化合物25-羟基-3-氧代齐墩果-12-烯-28-酸诱导乳腺癌细胞生长停滞和凋亡。
Breast Cancer Res Treat. 2007 Jan;101(1):27-36. doi: 10.1007/s10549-006-9275-z.
8
Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis.重组PML腺病毒通过诱导G1期细胞周期阻滞和凋亡来抑制人乳腺癌细胞的生长和致瘤性。
Oncogene. 1998 Apr 9;16(14):1839-49. doi: 10.1038/sj.onc.1201705.
9
Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis.干扰素调节因子-1(IRF-1)在乳腺癌中表现出肿瘤抑制活性,这与半胱天冬酶激活和细胞凋亡诱导有关。
Carcinogenesis. 2005 Sep;26(9):1527-35. doi: 10.1093/carcin/bgi113. Epub 2005 May 5.
10
A novel anthracene derivative, MHY412, induces apoptosis in doxorubicin-resistant MCF-7/Adr human breast cancer cells through cell cycle arrest and downregulation of P-glycoprotein expression.一种新型蒽衍生物 MHY412 通过细胞周期阻滞和下调 P-糖蛋白表达诱导多柔比星耐药 MCF-7/Adr 人乳腺癌细胞凋亡。
Int J Oncol. 2014 Jan;44(1):167-76. doi: 10.3892/ijo.2013.2160. Epub 2013 Oct 31.

引用本文的文献

1
Jet lag-induced circadian disruption elevates glioma risk by altering molecular profiles in distinct brain regions.时差导致的昼夜节律紊乱通过改变不同脑区的分子特征来提高患胶质瘤的风险。
Discov Oncol. 2025 Jul 26;16(1):1410. doi: 10.1007/s12672-025-03253-0.
2
Polymorphisms in circadian rhythm genes and the risk of differentiated thyroid cancer.昼夜节律基因多态性与分化型甲状腺癌风险
Front Genet. 2025 Jun 4;16:1539090. doi: 10.3389/fgene.2025.1539090. eCollection 2025.
3
Decoding Multifaceted Roles of Sleep-Related Genes as Molecular Bridges in Chronic Disease Pathogenesis.

本文引用的文献

1
The clock gene Per2 links the circadian system to the estrogen receptor.生物钟基因Per2将昼夜节律系统与雌激素受体联系起来。
Oncogene. 2007 Dec 13;26(57):7916-20. doi: 10.1038/sj.onc.1210585. Epub 2007 Jun 18.
2
Post-translational modifications regulate the ticking of the circadian clock.翻译后修饰调节生物钟的运转。
Nat Rev Mol Cell Biol. 2007 Feb;8(2):139-48. doi: 10.1038/nrm2106.
3
Shift work, light at night and risk of breast cancer.轮班工作、夜间光照与乳腺癌风险
解码睡眠相关基因在慢性疾病发病机制中作为分子桥梁的多方面作用。
Int J Mol Sci. 2025 Mar 21;26(7):2872. doi: 10.3390/ijms26072872.
4
A prognostic model of lung adenocarcinoma constructed based on circadian rhythm genes and its potential clinical significance.基于昼夜节律基因构建的肺腺癌预后模型及其潜在临床意义。
Front Oncol. 2025 Feb 18;15:1464578. doi: 10.3389/fonc.2025.1464578. eCollection 2025.
5
Circadian rhythms and breast cancer: from molecular level to therapeutic advancements.昼夜节律与乳腺癌:从分子水平到治疗进展。
J Cancer Res Clin Oncol. 2024 Sep 12;150(9):419. doi: 10.1007/s00432-024-05917-w.
6
Circadian rhythms and breast cancer: unraveling the biological clock's role in tumor microenvironment and ageing.昼夜节律与乳腺癌:揭示生物钟在肿瘤微环境和衰老中的作用。
Front Immunol. 2024 Jul 30;15:1444426. doi: 10.3389/fimmu.2024.1444426. eCollection 2024.
7
Crosstalk between Circadian Rhythm Dysregulation and Tumorigenesis, Tumor Metabolism and Tumor Immune Response.昼夜节律失调与肿瘤发生、肿瘤代谢及肿瘤免疫反应之间的相互作用
Aging Dis. 2024 Jul 2. doi: 10.14336/AD.2024.0533.
8
Circadian rhythm as a key player in cancer progression as well as a therapeutic target in -positive advanced gastric cancer treatment.昼夜节律是癌症进展的关键因素,也是阳性晚期胃癌治疗的一个治疗靶点。
Front Oncol. 2023 Jul 12;13:1240676. doi: 10.3389/fonc.2023.1240676. eCollection 2023.
9
Circadian Synchrony: Sleep, Nutrition, and Physical Activity.昼夜节律同步:睡眠、营养与身体活动。
Front Netw Physiol. 2021 Oct;1. doi: 10.3389/fnetp.2021.732243. Epub 2021 Oct 12.
10
Understanding the significance of biological clock and its impact on cancer incidence.了解生物钟的意义及其对癌症发病率的影响。
Cancer Lett. 2022 Feb 28;527:80-94. doi: 10.1016/j.canlet.2021.12.006. Epub 2021 Dec 11.
Occup Med (Lond). 2006 Sep;56(6):433. doi: 10.1093/occmed/kql078.
4
Circadian gene mPer2 overexpression induces cancer cell apoptosis.昼夜节律基因mPer2过表达诱导癌细胞凋亡。
Cancer Sci. 2006 Jul;97(7):589-96. doi: 10.1111/j.1349-7006.2006.00225.x.
5
Circadian disruption, shift work and the risk of cancer: a summary of the evidence and studies in Seattle.昼夜节律紊乱、轮班工作与癌症风险:西雅图的证据与研究综述
Cancer Causes Control. 2006 May;17(4):539-45. doi: 10.1007/s10552-005-9010-9.
6
Disruption of circadian coordination and malignant growth.昼夜节律协调的破坏与恶性生长。
Cancer Causes Control. 2006 May;17(4):509-14. doi: 10.1007/s10552-005-9007-4.
7
Circadian disruption and breast cancer: from melatonin to clock genes.昼夜节律紊乱与乳腺癌:从褪黑素到生物钟基因
Epidemiology. 2005 Mar;16(2):254-8. doi: 10.1097/01.ede.0000152525.21924.54.
8
The circadian timing system: making sense of day/night gene expression.昼夜节律计时系统:解读昼夜基因表达
Biol Res. 2004;37(1):11-28. doi: 10.4067/s0716-97602004000100003.
9
Disruption of circadian coordination accelerates malignant growth in mice.昼夜节律协调的破坏会加速小鼠的恶性肿瘤生长。
Pathol Biol (Paris). 2003 Jun;51(4):216-9. doi: 10.1016/s0369-8114(03)00034-8.
10
The mammalian circadian clock.哺乳动物的生物钟。
Curr Opin Genet Dev. 2003 Jun;13(3):271-7. doi: 10.1016/s0959-437x(03)00055-8.